Purinergic Signalling in Parkinson’s Disease: A Multi-target System to Combat Neurodegeneration
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-6903
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Purinergic Signalling in Parkinson’s Disease: A Multi-target System to Combat Neurodegeneration ; day:4 ; month:5 ; year:2019 ; pages:1-10
Neurochemical research ; (4.5.2019), 1-10
- Urheber
-
Tóth, Adrián
Antal, Zsófia
Bereczki, Dániel
Sperlágh, Beáta
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11064-019-02798-1
- URN
-
urn:nbn:de:101:1-2019061921360697409943
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tóth, Adrián
- Antal, Zsófia
- Bereczki, Dániel
- Sperlágh, Beáta
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
Molekulare Mechanismen der Neurodegeneration bei Morbus Parkinson
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease
Two distinct trajectories of clinical and neurodegeneration events in Parkinson’s disease
GPR37 processing in neurodegeneration: a potential marker for Parkinson’s Disease progression rate
Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease
Author Correction: Two distinct trajectories of clinical and neurodegeneration events in Parkinson’s disease
Serum neurofilament indicates accelerated neurodegeneration and predicts mortality in late-stage Parkinson’s disease
Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model
Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson’s disease model
Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration
Parkinson's and Alzheimer's today : about neurodegeneration and its therapy
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
Molekulare Mechanismen der Neurodegeneration bei Morbus Parkinson
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease
Two distinct trajectories of clinical and neurodegeneration events in Parkinson’s disease
GPR37 processing in neurodegeneration: a potential marker for Parkinson’s Disease progression rate
Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease
Author Correction: Two distinct trajectories of clinical and neurodegeneration events in Parkinson’s disease
Serum neurofilament indicates accelerated neurodegeneration and predicts mortality in late-stage Parkinson’s disease
Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model
Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson’s disease model
Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration
Parkinson's and Alzheimer's today : about neurodegeneration and its therapy
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
Molekulare Mechanismen der Neurodegeneration bei Morbus Parkinson
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease
Two distinct trajectories of clinical and neurodegeneration events in Parkinson’s disease
GPR37 processing in neurodegeneration: a potential marker for Parkinson’s Disease progression rate
Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease
Author Correction: Two distinct trajectories of clinical and neurodegeneration events in Parkinson’s disease
Serum neurofilament indicates accelerated neurodegeneration and predicts mortality in late-stage Parkinson’s disease
Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model
Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson’s disease model
Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration